Tevogen Bio Holdings Inc (TVGN) USD0.0001 A
Sell:$1.05Buy:$1.12
$0.02
(1.83%)
- This stock can be held in a
Stocks and Shares ISA$0.02
(1.83%)$0.02
(1.83%)Company Information
About this company
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.
Key people
Key facts
- EPICTVGN
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS88165K1016
- Market cap$190.81m
- Employees17
- Shares in issue175.05m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.